THE IMMUNE-SYSTEM IN FAMILIAL MEDITERRANEAN FEVER
- 1 January 1983
- journal article
- research article
- Vol. 53 (3) , 659-662
Abstract
Familial Mediterranean fever (FMF) is a genetic disorder with an obscure etiology. In attempts to investigate a possible immunoregulatory imbalance involved in this disease, 24 FMF patients were tested for suppressor T cell activity and for chemotaxis of mononuclear cells. The suppressor T cell activity and chemotaxis were decreased in untreated FMF patients as compared to colchicine treated patients or normal controls. Amyloid FMF patients manifested significantly increased chemotactic activity, while the suppressor T cell activity was normal. This finding may extend the knowledge concerning the immune mechanism involved in FMF.This publication has 11 references indexed in Scilit:
- Molecular and Cellular Mechanisms of Leukocyte ChemotaxisScience, 1981
- Immunoregulatory abnormalities in familial Mediterranean feverClinical Immunology and Immunopathology, 1981
- Monocyte function in familial Mediterranean feverThe Lancet Healthy Longevity, 1977
- Effect of prophylactic colchicine therapy on leukocyte function in patients with familial mediterranean feverArthritis & Rheumatism, 1976
- Colchicine in Familial Mediterranean FeverNew England Journal of Medicine, 1976
- Leukocyte function in familial mediterranean feverAmerican Journal of Hematology, 1976
- Colchicine Therapy for Familial Mediterranean FeverNew England Journal of Medicine, 1974
- A Controlled Trial of Colchicine in Preventing Attacks of Familial Mediterranean FeverNew England Journal of Medicine, 1974
- Incidence of amyloidosis in recurrent polyserositis (familial Mediterranean fever).1970
- Familial Mediterranean feverThe American Journal of Medicine, 1967